The Evolutionary Landscape of Treatment for BRAF(V600E) Mutant Metastatic Colorectal Cancer

SIMPLE SUMMARY: The BRAF(V600E) mutation accounts for 8–10% of metastatic colorectal cancer (mCRC) patients and it is an established prognostic factor. Median overall survival of this subset of patients is indeed so poor that it is similar to first line PFS of patients without this molecular alterat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauri, Gianluca, Bonazzina, Erica, Amatu, Alessio, Tosi, Federica, Bencardino, Katia, Gori, Viviana, Massihnia, Daniela, Cipani, Tiziana, Spina, Francesco, Ghezzi, Silvia, Siena, Salvatore, Sartore-Bianchi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795863/
https://www.ncbi.nlm.nih.gov/pubmed/33406649
http://dx.doi.org/10.3390/cancers13010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795863/
https://www.ncbi.nlm.nih.gov/pubmed/33406649
http://dx.doi.org/10.3390/cancers13010137

Ejemplares similares